Clinical Trials Browser

Withdrawn × Ovarian Neoplasms × Sirolimus × Clear all

NCT02833506 2018-05-01

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1 Withdrawn

Fallopian Tube Neoplasms, Ovarian Neoplasms